Fabhalta 200 MG
Ended Awarded
- Contract number
- 36C24526N0323
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $34,874
Award facts
- Contract value 100% obligated
- $34,873.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cary, NC 27513, USA
Award details come from SAM.gov/FPDS.
About this award
Novartis Pharmaceuticals Corporation was awarded a delivery order valued at $34,873.77 by Veterans Integrated Service Network 5 (VISN 5) for FABHALTA 200 mg, a specialized pharmaceutical product supporting the Department of Veterans Affairs' healthcare mission. This firm fixed-price delivery order, with a completion date of February 23, 2026, was issued without a small business set-aside designation and reflects Novartis' role as a large pharmaceutical manufacturer competing directly in the federal marketplace. The contract performance location is Cary, North Carolina.
This delivery order is issued under Novartis' broader Blanket Purchase Agreement with the National Acquisition Center, a single-award vehicle effective October 2, 2025, with a ceiling value of $61.1 million through October 1, 2026. The BPA authorizes procurement of four specialized pharmaceutical products—KYMRIAH, FABHALTA, NETSPOT, and LOCAMETZ—under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Novartis' extensive federal contract portfolio demonstrates the company's status as a major federal supplier of oncology treatments and radiopharmaceutical products to the VA and Defense Health Agency, with delivery orders spanning multiple VISNs and performance locations nationwide.
Quick answers
Who was awarded contract 36C24526N0323?
36C24526N0323 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 12, 2026.
How much is contract 36C24526N0323 worth?
The government has obligated $34,874 on 36C24526N0323.
Is contract 36C24526N0323 an order under another contract?
Yes. 36C24526N0323 is a delivery order under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0323 competed?
The extent of competition for 36C24526N0323 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award